Monday, December 10, 2012

Cloned Receptor Paves Way for New Breast and Prostate Cancer Treatment

According to Science Daily, researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. It is said that genetically modified T cells (white blood corpuscles) have recently been shown to be extremely effective in treating certain forms of advanced cancer. T cells from the patient's own blood cells are isolated and equipped by genetic means with a new receptor that recognizes an antigen that is expressed in the tumour cells. These T cells are cultivated in a special clean room and then administered to the patient. Once inside the body, they seek out sub tumours and individual tumour cells and eliminate them.

This can be a huge break through in cancer treatment. They say "This is the first time anyone has succeeded in cloning a T-cell receptor targeting prostate antigen, and we hope we will have an opportunity to test T cells equipped with this receptor in a clinical study. In order to do so, we will probably need to enlist the help of American colleagues." It is incredible that there has been all of these studies that can have such a huge impact on so many peoples lives. I have a few people I know with cancer, and I believe the cure is out there somewhere.

No comments:

Post a Comment